Actively Recruiting

Phase 3
Age: 18Years +
MALE
NCT05903859

Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)

Led by University of Miami · Updated on 2026-03-02

90

Participants Needed

1

Research Sites

258 weeks

Total Duration

On this page

Sponsors

U

University of Miami

Lead Sponsor

C

Congressionally Directed Medical Research Programs

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a study of infertility which often occurs in men with spinal cord injury. Most men with spinal cord injury have a normal sperm count but abnormally low sperm motility - which means that the sperm does not swim well. This study will determine if a medicine given by mouth will improve sperm motility in men with spinal cord injuries. The medicine is called probenecid.

CONDITIONS

Official Title

Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject has a traumatic spinal cord injury.
  • Subject is male and is 18 years or older.
Not Eligible

You will not qualify if you...

  • Subject has been injured less than 1 year.
  • The subject is known to be azoospermic.
  • The subject has an indwelling urethral Foley catheter.
  • Subject is under the age of 18 years.
  • Subject has an unstable medical condition including Crohn's disease, ulcerative colitis, colon cancer, or other conditions deemed exclusionary.
  • Subject is unable to consent or understand the study procedures.
  • Subject has a permanent implanted electrical device like a pacemaker or spinal cord stimulator.
  • Procedure or medication is contraindicated for the subject.
  • Subject has hypersensitivity to probenecid.
  • Subject has a history of uric acid kidney stones or peptic ulcer.
  • Subject had a febrile urinary tract infection within 2 months before enrollment.
  • Subject is taking methotrexate, aspirin, other salicylates, or anti-inflammatory medicines.
  • Subject has a history of Glucose-6-phosphate dehydrogenase (G6PD) deficiency.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Miami

Miami, Florida, United States, 33136

Actively Recruiting

Loading map...

Research Team

O

Odaro Ugbo, BSc

CONTACT

O

Orrey Padilla

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here